Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2011.12.240
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation
TransplantationHematology
2016English

Choosing a Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation, Fludarabine Busulfan Versus Fludarabine Melphalan: A Systematic Review and Meta-Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan With Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem-Cell Transplantation in the Modern Era: A Cohort Analysis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin

Neoplasma
Cancer Research
2011English

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Non-Hodgkin Lymphoma: A Nationwide Survey in Japan

Blood
BiochemistryImmunologyCell BiologyHematology
2006English

Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Myeloablative Conditioning for Hematopoietic Stem-Cell Transplantation in Patients With Non-Malignant Diseases

Bone Marrow Transplantation
TransplantationHematology
2006English

Thiotepa, Busulfan and Fludarabine Compared to Busulfan and Cyclophosphamide as Conditioning Regimen for Allogeneic Stem Cell Transplant From Matched Siblings and Unrelated Donors for Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy